Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy

Clinical trial NCT06174220 · RECRUITING

Trial details

NCT number: NCT06174220
Sponsor: Hamilton Health Sciences Corporation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Arrhythmogenic Cardiomyopathy Arrhythmogenic Right Ventricular Cardiomyopathy

Start date: 2025-03-21
Primary completion: 2027-02-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.